A Novel Method for the Determination of Vancomycin in Serum by High-Performance Liquid Chromatography-Tandem Mass Spectrometry and Its Application in Patients with Diabetic Foot Infections
Open Access
- 10 November 2018
- Vol. 23 (11) , 2939
Abstract
A novel, precise, and accurate high-performance liquid chromatography-tandem mass spectrometry (Q-trap-MS) method was developed, optimized, and validated for determination of vancomycin in human serum using norvancomycin as an internal standard. Effect of different parameters on the analysis was evaluated. ZORBAX SB-C18 column (150 × 4.6 mm, 5 μm) using water (containing 0.1% formic acid, v/v)–acetonitrile (containing 0.1% formic acid, v/v) as a mobile phase was chosen. The calibration curve was linear over the concentration ranges of 1 to 2000 ng/mL for vancomycin. The limit of detection (LOD) and limit of quantification (LOQ) for vancomycin were 0.3 and 1.0 ng/mL. Recoveries were between 87.2 and 102.3%, which gave satisfactory precision. A total of 100 serum samples (from 50 patients with diabetic foot proven Gram-positive infection and 50 nondiabetic patients with pneumonia requiring hospitalization and antibiotic therapy) were analyzed by this method. The trough vancomycin concentrations of diabetic foot infection (DFI) patients and nondiabetic patients were 8.20 ± 2.83 μg/mL (range: 4.80–14.2 μg/mL) and 15.80 ± 5.43 μg/mL (range: 8.60–19.5 μg/mL), respectively. The method is sensitive, precise, and reproducible, it could be applied for routine laboratory analysis of vancomycin in serum samples.Keywords
Funding Information
- CAMS Innovation Fund for Medical Sciences (CIFMS) (No. 2016-I2M-1-001)
This publication has 47 references indexed in Scilit:
- Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapyJournal of Critical Care, 2013
- Quantification of vancomycin in human serum by LC-MS/MSClinical Chemistry and Laboratory Medicine (CCLM), 2013
- Determination of Tissue Penetration and Pharmacokinetics of Linezolid in Patients with Diabetic Foot Infections Using In Vivo MicrodialysisAntimicrobial Agents and Chemotherapy, 2011
- Implications of augmented renal clearance in critically ill patientsNature Reviews Nephrology, 2011
- Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: correlation with measured and estimated creatinine clearance and serum cystatin CInternational Journal of Antimicrobial Agents, 2010
- Can rodent models of diabetic kidney disease clarify the significance of early hyperfiltration?: recognizing clinical and experimental uncertaintiesClinical Science, 2007
- Bacteriology of Moderate-to-Severe Diabetic Foot Infections and In Vitro Activity of Antimicrobial AgentsJournal of Clinical Microbiology, 2007
- Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection?Clinical Microbiology and Infection, 2007
- Impaired Target Site Penetration of Vancomycin in Diabetic Patients following Cardiac SurgeryAntimicrobial Agents and Chemotherapy, 2006
- Diagnosis and Treatment of Diabetic Foot InfectionsClinical Infectious Diseases, 2004